Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Intermolecular Company Profile (NASDAQ:IMI)

Consensus Ratings for Intermolecular (NASDAQ:IMI) (?)
Ratings Breakdown: 1 Sell Rating(s), 1 Hold Rating(s)
Consensus Rating:Hold (Score: 1.50)
Consensus Price Target: $9.00 (239.62% upside)

Analysts' Ratings History for Intermolecular (NASDAQ:IMI)
Show:
DateFirmActionRatingPrice TargetDetailsShare
2/7/2014JPMorgan Chase & Co.Lower Price Target$12.00 -> $9.00ViewTweet This Rating  Share This Rating on StockTwits
1/6/2014Needham & Company LLCDowngradeBuy -> HoldViewTweet This Rating  Share This Rating on StockTwits
7/26/2013Needham & Company LLCLower Price TargetBuy$12.00 -> $10.00ViewTweet This Rating  Share This Rating on StockTwits
7/10/2013JPMorgan Chase & Co.DowngradeNeutralViewTweet This Rating  Share This Rating on StockTwits
7/10/2013JPMorgan Chase & Co.DowngradeOverweight -> Neutral$15.00 -> $12.00ViewTweet This Rating  Share This Rating on StockTwits
5/28/2013TheStreetDowngradeHold -> SellViewTweet This Rating  Share This Rating on StockTwits
4/18/2013Needham & Company LLCBoost Price Target$11.00 -> $12.00ViewTweet This Rating  Share This Rating on StockTwits
1/18/2013Needham & Company LLCBoost Price TargetBuy$10.00 -> $11.00ViewTweet This Rating  Share This Rating on StockTwits
6/25/2012Morgan StanleyInitiated CoverageEqualweightViewTweet This Rating  Share This Rating on StockTwits
4/27/2012JPMorgan Chase & Co.Lower Price TargetOverweight$17.00 -> $12.00ViewTweet This Rating  Share This Rating on StockTwits
4/27/2012Needham & Company LLCReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
4/27/2012Needham & Company LLCBoost Price TargetHold$10.00 -> $13.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 4/25/2012 forward)